The UVA clinical research infrastructure is once again fully operational. See a sample of trials actively accruing, with precautions in place to ensure the safety of patients and staff.
Tag: uva cancer center (Page 4)
Based on the results from a recent clinical trial, the guidelines for which patients should be screened for lung cancer may soon change.
Dr. El Chaer specializes in caring for patients with acute leukemias, including acute myeloid leukemia and acute lymphoblastic leukemia.
Focused ultrasound temporarily opens the blood-brain barrier to allow the delivery of more cancer-fighting agent to the tumor.
John Timothy (J.T.) Stranix, MD, is a plastic surgeon who specializes in microsurgery procedures, including autologous breast reconstruction.
In a recent article that appeared on UVA Today, Thomas Loughran, MD, discussed the role UVA has played in furthering this decades-long trend, improving outcomes for cancer patients, as well as advancing the treatment of the disease worldwide through ongoing clinical research.
Learn the most up-to-date and comprehensive information on oral therapies in lymphoma and chronic lymphocytic leukemia (CLL) by tuning in to a podcast featuring UVA Cancer Center Chief of the Division of Hematology/Oncology Michael E. Williams, MD, ScM.
With the addition of more specialty providers and expanded services, such as clinical trials and stem cell transplants, UVA Cancer Center is making improvements to better accommodate a greater number of patients.
To ensure the best outcome, in terms of both disease eradication and preserving the appearance and functionality of the eye, UVA brought together skilled providers from dermatopathology, dermatologic surgery and ophthalmology.
CAR T-cell therapy was just approved by the U.S. Food and Drug Administration for commercial use in adult patients with refractory and relapsed lymphoma.